ACTIVE

LIEPHAR

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

73,2 k €

-46.8% YoY

Gross margin

332,5 k €

+6.6% YoY

Equity

846,0 k €

+2.8% YoY

Workforce

3,1 ETP

0.0% YoY

What does LIEPHAR do?

LIEPHAR is a Public limited company incorporated in 2004. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Mettet. It employs on average 3,1 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0862.571.213

Incorporation

12/01/2004

Legal form

Public limited company

Registered office

Place Joseph Meunier 11
5640 Mettet · WallonieSee on map

Contributed capital

150 000,00 €

Latest accounts

31/12/2025

Average workforce

3,1 ETP

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores 52310Warehousing and support activities for transportation

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 20 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	332,5 k €	+6.6%	311,8 k €	+28.9%	242,0 k €	+0.9%	239,9 k €	+3.9%	231,0 k €	+74.5%	132,3 k €	-18.6%	162,5 k €	-25.1%	216,8 k €	-16.2%	258,6 k €	-5.9%	274,9 k €	-0.9%	277,4 k €	+30.9%	211,9 k €	+6.7%	198,6 k €	-2.7%	204,1 k €	-18.8%	251,5 k €	-6.6%	269,3 k €	+1.7%	264,7 k €	+15.5%	229,2 k €	+20.5%	190,2 k €	+3.4%	183,9 k €
EBITDA	203,9 k €	+10.4%	184,7 k €	+37.5%	134,4 k €	-10.3%	149,8 k €	-3.4%	155,1 k €	+141%	64,4 k €	-38.5%	104,6 k €	-30.3%	150,0 k €	-21.2%	190,3 k €	-4.7%	199,7 k €	-5.1%	210,4 k €	+42.1%	148,1 k €	+14.4%	129,5 k €	-11.1%	145,7 k €	-24.0%	191,7 k €	-5.4%	202,6 k €	+3.5%	195,8 k €	+10.7%	176,8 k €	+17.9%	149,9 k €	+29.1%	116,1 k €
Operating result	99,8 k €	-39.9%	166,0 k €	+34.2%	123,7 k €	-0.3%	124,1 k €	-17.1%	149,7 k €	+192%	51,3 k €	-43.4%	90,6 k €	-34.1%	137,4 k €	-22.7%	177,7 k €	+8.9%	163,1 k €	+0.5%	162,4 k €	+62.3%	100,0 k €	+107%	48,3 k €	-25.7%	65,0 k €	-39.5%	107,3 k €	-15.1%	126,4 k €	+5.5%	119,9 k €	+25.0%	95,9 k €	+34.6%	71,2 k €	+21.8%	58,4 k €
Net result	73,2 k €	-46.8%	137,7 k €	+28.5%	107,2 k €	+1.0%	106,1 k €	-15.2%	125,1 k €	+214%	39,8 k €	-36.3%	62,5 k €	-33.7%	94,3 k €	-17.2%	113,9 k €	+7.5%	105,9 k €	+0.3%	105,6 k €	+65.4%	63,8 k €	+86.0%	34,3 k €	-12.7%	39,3 k €	-44.1%	70,3 k €	-11.3%	79,2 k €	+3.7%	76,4 k €	+38.4%	55,2 k €	+41.4%	39,0 k €	+43.1%	27,3 k €
Balance sheet
Equity	846,0 k €	+2.8%	822,8 k €	+11.9%	735,0 k €	+3.8%	707,8 k €	+8.6%	651,7 k €	+8.3%	601,5 k €	+7.1%	561,7 k €	+12.5%	499,2 k €	+23.3%	404,9 k €	+39.1%	291,1 k €	+57.2%	185,2 k €	-42.1%	319,6 k €	+24.9%	255,8 k €	+6.1%	241,0 k €	-4.3%	251,7 k €	-7.3%	271,4 k €	-20.7%	342,2 k €	+19.9%	285,3 k €	+14.3%	249,6 k €	+6.8%	233,7 k €
Total assets	1,6 M €	-2.8%	1,6 M €	-0.5%	1,6 M €	+63.9%	1,0 M €	+26.7%	791,3 k €	+22.0%	648,5 k €	+6.5%	609,2 k €	-6.4%	651,2 k €	+7.4%	606,3 k €	+12.3%	540,0 k €	-15.8%	641,2 k €	+9.0%	588,4 k €	-0.4%	590,9 k €	-6.1%	629,0 k €	-10.3%	700,9 k €	-14.8%	822,2 k €	+2.5%	802,3 k €	+3.9%	772,2 k €	-0.0%	772,4 k €	+18.8%	650,2 k €
Cash	182,5 k €	+8.0%	169,0 k €	-46.9%	318,2 k €	+1.2%	314,5 k €	+26.0%	249,7 k €	+115%	115,9 k €	-26.9%	158,6 k €	-58.6%	383,2 k €	+19.8%	320,0 k €	+23.6%	258,9 k €	-19.1%	320,1 k €	+42.2%	225,1 k €	+4.8%	214,7 k €	+22.4%	175,5 k €	+10.2%	159,2 k €	-46.4%	296,9 k €	+25.4%	236,9 k €	+69.0%	140,2 k €	+44.7%	96,8 k €	-7.4%	104,5 k €
Debts	741,1 k €	-8.6%	810,8 k €	-10.6%	906,7 k €	+210%	292,6 k €	+110%	139,6 k €	+197%	47,0 k €	-1.1%	47,5 k €	-68.7%	151,9 k €	-24.5%	201,3 k €	-19.1%	248,9 k €	-45.4%	456,0 k €	+70.0%	268,2 k €	-19.9%	335,0 k €	-13.7%	388,0 k €	-13.6%	449,2 k €	-18.4%	550,8 k €	+19.7%	460,1 k €	-5.5%	486,9 k €	-6.9%	522,8 k €	+25.5%	416,5 k €
Other
Workforce	3,1 ETP	0.0%	3,1 ETP	+34.8%	2,3 ETP	+9.5%	2,1 ETP	0.0%	2,1 ETP	+10.5%	1,9 ETP	+26.7%	1,5 ETP	-28.6%	2,1 ETP	-4.5%	2,2 ETP	0.0%	2,2 ETP	-8.3%	2,4 ETP	+20.0%	2,0 ETP	0.0%	2,0 ETP	0.0%	2,0 ETP	0.0%	2,0 ETP	-9.1%	2,2 ETP	-4.3%	2,3 ETP	+15.0%	2,0 ETP	-13.0%	2,3 ETP	0.0%	2,3 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 19 ended

Active mandates

LIEPHARM

Director · since 01 juin 2025 · until 30 mai 2031 · 0728.704.778

Active

Michel MEERT

Director · since 01 juin 2025 · until 30 mai 2031

Active

Ended mandates

MICHEL MEERT

Director · since 03 janvier 2020 · until 30 mai 2025

Ended

Michel MEERT

Director · since 30 septembre 2019 · until 30 mai 2025

Ended

JACQUELINE MOUCHART

Director · since 04 septembre 2019 · until 03 janvier 2020

Ended

JACQUELINE MOUCHART

Director · since 04 septembre 2019 · until 30 mai 2025

Ended

At this address

Other companies at this address

Company	CBE no.
LIEPHARM● Active	0728.704.778

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	30/07/2026	30/07/2025	21/08/2024	01/09/2023	13/07/2022	30/08/2021
General meeting	30/05/2026	30/05/2025	30/05/2024	30/05/2023	30/05/2022	31/05/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	30/05/2026	30/07/2026	French	PDF
Abridged model	31/12/2024	30/05/2025	30/07/2025	French	PDF
Abridged model	31/12/2023	30/05/2024	21/08/2024	French	PDF
Abridged model	31/12/2022	30/05/2023	01/09/2023	French	PDF
Abridged model	31/12/2021	30/05/2022	13/07/2022	French	PDF
Abridged model	31/12/2020	31/05/2021	30/08/2021	French	PDF
Abridged model	31/12/2019	30/05/2020	26/06/2020	French	PDF
Abridged model	31/12/2018	31/05/2019	27/06/2019	French	PDF
Abridged model	31/12/2017	30/05/2018	30/07/2018	French	PDF
Abridged model	31/12/2016	30/05/2017	09/06/2017	French	PDF
Abridged model	31/12/2015	30/05/2016	16/08/2016	French	PDF
Abridged model	31/12/2014	30/05/2015	14/08/2015	French	PDF
Abridged model	31/12/2013	30/05/2014	07/08/2014	French	PDF
Abridged model	31/12/2012	30/05/2013	11/07/2013	French	PDF
Abridged model	31/12/2011	25/05/2012	05/06/2012	French	PDF
Abridged model	31/12/2010	27/05/2011	06/07/2011	French	PDF
Abridged model	31/12/2009	28/05/2010	29/07/2010	French	PDF
Abridged model	31/12/2008	29/05/2009	08/08/2009	French	PDF
Abridged model	31/12/2007	30/05/2008	26/08/2008	French	PDF
Abridged model	31/12/2006	28/05/2007	30/07/2007	French	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 19 ended

Active mandates

LIEPHARM

Director · since 01 juin 2025 · until 30 mai 2031 · 0728.704.778

Active

Michel MEERT

Director · since 01 juin 2025 · until 30 mai 2031

Active

Ended mandates

MICHEL MEERT

Director · since 03 janvier 2020 · until 30 mai 2025

Ended

Michel MEERT

Director · since 30 septembre 2019 · until 30 mai 2025

Ended

JACQUELINE MOUCHART

Director · since 04 septembre 2019 · until 03 janvier 2020

Ended

JACQUELINE MOUCHART

Director · since 04 septembre 2019 · until 30 mai 2025

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates03/07/2025
DEMISSIONS, NOMINATIONS
PDF
Mandates10/01/2020
DEMISSIONS, NOMINATIONS
PDF
Mandates24/09/2019
DEMISSIONS, NOMINATIONS
PDF
Mandates29/10/2015
DEMISSIONS, NOMINATIONS
PDF
Mandates22/03/2013
DEMISSIONS, NOMINATIONS
PDF
Other04/06/2004
DIVERS
PDF
Other19/01/2004
RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 202573,2 k €↓
2024
Annual accounts 2024137,7 k €↑
2023
Annual accounts 2023107,2 k €↑
2022
Annual accounts 2022106,1 k €↓
2021
Annual accounts 2021125,1 k €↑
2020
Annual accounts 202039,8 k €↓
2019
Annual accounts 201962,5 k €↓
2018
Annual accounts 201894,3 k €↓
2017
Annual accounts 2017113,9 k €↑
2016
Annual accounts 2016105,9 k €↑
2015
Annual accounts 2015105,6 k €↑
2014
Annual accounts 201463,8 k €↑
2013
Annual accounts 201334,3 k €↓
2012
Annual accounts 201239,3 k €↓
2011
Annual accounts 201170,3 k €↓
2010
Annual accounts 201079,2 k €↑
2009
Annual accounts 200976,4 k €↑
2008
Annual accounts 200855,2 k €↑
2007
Annual accounts 200739,0 k €↑
2006
Annual accounts 200627,3 k €
12/01/2004
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

LIEPHAR

Overview

What does LIEPHAR do?

Trend over 20 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline